Iron: The new advances in therapy

Best Practice and Research: Clinical Anaesthesiology

Volumn 27, Issue 1, 2013, Pages 131-140

  Auerbach, Michael ^a,b   Goodnough, Lawrence Tim ^c   Shander, Aryeh ^d  

^a Hematology/Oncology Division   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

anaemia; erythropoietin; hepcidin; iron

Indexed keywords

FERRIC CARBOXYMALTOSE; FERUMOXYTOL; HEPCIDIN; IRON; IRON DEXTRAN;

ANEMIA; HUMAN; IRON DEFICIENCY; IRON STORAGE; IRON THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 84876274106     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2012.12.001     Document Type: Review

References (79)

1. L.T. Goodnough, E. Nemeth, and T. Ganz Detection, evaluation, and management of iron-restricted erythropoiesis Blood 116 23 2010 4754 4761
2. L.T. Goodnough Iron deficiency syndromes and iron-restricted erythropoiesis (CME) Transfusion 52 7 2012 1584 1592
3. G.H. Guyatt, C. Patterson, and M. Ali Diagnosis of iron-deficiency anemia in the elderly Am J Med 88 3 1990 205 209
4. J.M. Guralnik, R.S. Eisenstaedt, and L. Ferrucci Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia Blood 104 8 2004 2263 2268
5. B. Annibale, G. Capurso, and A. Chistolini Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms Am J Med 111 6 2001 439 445
6. P.L. Acher, T. Al-Mishlab, and M. Rahman Iron-deficiency anaemia and delay in the diagnosis of colorectal cancer Colorectal Dis 5 2 2003 145 148
7. D. Raje, H. Mukhtar, and A. Oshowo What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer? Dis Colon Rectum 50 8 2007 1211 1214
8. C.A. Finch Erythropoiesis, erythropoietin, and iron Blood 60 6 1982 1241 1246
9. W.H. Crosby The metabolism of hemoglobin and bile pigment in hemolytic disease Am J Med 18 1 1955 112 122
10. R.S. Hillman, and P.A. Henderson Control of marrow production by the level of iron supply J Clin Invest 48 3 1969 454 460
11. C.A. Finch, and H. Huebers Perspectives in iron metabolism N Engl J Med 306 25 1982 1520 1528
12. L.T. Goodnough, T.H. Price, and K.D. Friedman A phase trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy Transfusion 34 1 1994 66 71
13. T. Sans, C. Bofil, and J. Joven Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery Transfusion 36 9 1996 822 826
14. L.T. Goodnough, T.H. Price, and S. Rudnick Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy Transfusion 32 5 1992 441 445
15. L.T. Goodnough, T.H. Price, and C.A. Parvin The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender J Lab Clin Med 126 1 1995 57 64
16. L.T. Goodnough, D. Verbrugge, and R.E. Marcus The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation J Am Coll Surg 179 2 1994 171 176
17. C. Brugnara, L.A. Chambers, and E. Malynn Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects Blood 81 4 1993 956 964
18. J.W. Eschbach, N.R. Haley, and J.C. Egrie A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects Kidney Int 42 2 1992 407 416
19. B.S. Spinowitz, A.T. Kausz, and J. Baptista Ferumoxytol for treating iron deficiency anemia in CKD J Am Soc Nephrol 19 8 2008 1599 1605
20. M. Auerbach, H. Ballard, and J.R. Trout Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial J Clin Oncol 22 7 2004 1301 1307
21. D.H. Henry, N.V. Dahl, and M. Auerbach Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy Oncologist 12 2 2007 231 242
22. T. Ganz Hepcidin and iron regulation, 10 years later Blood 117 17 2011 4425 4433
23. T. Ganz, G. Olbina, and D. Girelli Immunoassay for human serum hepcidin Blood 112 10 2008 4292 4297
24. D.R. Ashby, D.P. Gale, and M. Busbridge Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin Haematologica 95 3 2010 505 508
25. E. Nemeth Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias Adv Hematol 2010 2010 750643
26. M. Pak, M.A. Lopez, and V. Gabayan Suppression of hepcidin during anemia requires erythropoietic activity Blood 108 12 2006 3730 3735
27. T. Tanno, and J.L. Miller Iron loading and overloading due to ineffective erythropoiesis Adv Hematol 2010 2010 358283
28. C. Peyssonnaux, A.S. Zinkernagel, and R.A. Schuepbach Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs) J Clin Invest 117 7 2007 1926 1932
29. G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 10 2005 1011 1023
30. B. Young, and J. Zaritsky Hepcidin for clinicians Clin J Am Soc Nephrol 4 8 2009 1384 1387
31. I. Theurl, E. Aigner, and M. Theurl Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications Blood 113 21 2009 5277 5286
32. J. Bonnar, A. Goldberg, and J.A. Smith Do pregnant women take their iron? Lancet 1 7592 1969 457 458
33. M. Hedenus, G. Birgegard, and P. Nasman Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study Leukemia 21 4 2007 627 632
34. L. Bastit, A. Vandebroek, and S. Altintas Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia J Clin Oncol 26 10 2008 1611 1618
35. R.L. Jurado Iron, infections, and anemia of inflammation Clin Infect Dis 25 4 1997 888 895
36. K. Bishu, and R. Agarwal Acute injury with intravenous iron and concerns regarding long-term safety Clin J Am Soc Nephrol 1 Suppl. 1 2006 S19 S23
37. M. Auerbach, and H. Ballard Clinical use of intravenous iron: administration, efficacy, and safety Hematology Am Soc Hematol Educ Program 2010 2010 338 347
38. S. Sinha, D.Y. Chiu, and G. Peebles Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease J Ren Care 35 2 2009 67 73
39. S. Sinha, D.Y. Chiu, and G. Peebles The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease Nephrol Dial Transplant 2 2009 432 433
40. G.M. Rodgers, M. Auerbach, and D. Cella High-molecular weight iron dextran: a wolf in sheep's clothing? J Am Soc Nephrol 19 5 2008 833 834
41. M. Auerbach, D. Witt, and W. Toler Clinical use of the total dose intravenous infusion of iron dextran J Lab Clin Med 111 5 1988 566 570
42. M. Auerbach, J. Winchester, and A. Wahab A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients Am J Kidney Dis 31 1 1998 81 86
43. C.M. Reddy, S.K. Kathula, and S.A. Ali Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia Int J Clin Pract 62 3 2008 413 415
44. J.C. Barton, E.H. Barton, and L.F. Bertoli Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation Am J Med 109 1 2000 27 32
45. I.E. Koutroubakis, P. Oustamanolakis, and C. Karakoidas Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease Dig Dis Sci 55 8 2010 2327 2331
46. M. Auerbach, J.A. Pappadakis, and H. Bahrain Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia Am J Hematol 86 10 2011 860 862
47. M. Garg, G. Morrison, and A. Friedman A rapid infusion protocol is safe for total dose iron polymaltose: time for change Intern Med J 41 7 2011 548 554
48. Auerbach M, Auerbach SA, Bahrain H. Safety and efficacy of total dose infusion of ferumoxytol 1020 mg administered in 15 minutes 2011.
49. A. Singh, T. Patel, and J. Hertel Safety of ferumoxytol in patients with anemia and CKD Am J Kidney Dis 52 5 2008 907 915
50. M.H. Rosner, and M. Auerbach Ferumoxytol for the treatment of iron deficiency Expert Rev Hematol 4 4 2011 399 406
51. D.B. Van Wyck, A. Mangione, and J. Morrison Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial Transfusion 49 12 2009 2719 2728
52. S. Kulnigg, S. Stoinov, and V. Simanenkov A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial Am J Gastroenterol 103 5 2008 1182 1192
53. Steinmetz H, Tschechne B, Virgin G. Effectiveness and tolerability of ferric carboxymaltose in the correction of cancer-and chemotherapy-associated anaemia - a multicenter observational study 2011:S221-2.
54. S.D. Anker, C.J. Comin, and G. Filippatos Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 25 2009 2436 2448
55. A. Covic, and G. Mircescu The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study Nephrol Dial Transplant 25 8 2010 2722 2730
56. K.A. Lyseng-Williamson, and G.M. Keating Ferric carboxymaltose: a review of its use in iron-deficiency anaemia Drugs 69 6 2009 739 756
57. B. Wikstrom, S. Bhandari, and P. Barany Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease J Nephrol 24 5 2011 589 596
58. B. Michael, D.W. Coyne, and V.W. Folkert Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safety Nephrol Dial Transplant 19 6 2004 1576 1580
59. D.W. Coyne, N.F. Adkinson, and A.R. Nissenson Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients Kidney Int 63 1 2003 217 224
60. P. Pedrazzoli, A. Farris, and P.S. Del Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha J Clin Oncol 26 10 2008 1619 1625
61. V.W. Folkert, B. Michael, and R. Agarwal Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration Am J Kidney Dis 41 3 2003 651 657
62. G.R. Aronoff, W.M. Bennett, and S. Blumenthal Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens Kidney Int 66 3 2004 1193 1198
63. C. Charytan, M.H. Schwenk, and M.M. Al-Saloum Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products Nephron Clin Pract 96 2 2004 c63 c66
64. D.B. Van Wyck, M. Roppolo, and C.O. Martinez A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD Kidney Int 68 6 2005 2846 2856
65. C. Gasche, C. Dejaco, and T. Waldhoer Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial Ann Intern Med 126 10 1997 782 787
66. C. Gasche, M.C. Lomer, and I. Cavill Iron, anaemia, and inflammatory bowel diseases Gut 53 8 2004 1190 1197
67. M. Auerbach, L.T. Goodnough, and D. Picard The role of intravenous iron in anemia management and transfusion avoidance Transfusion 48 5 2008 988 1000
68. G. Chandler, J. Harchowal, and I.C. Macdougall Intravenous iron sucrose: establishing a safe dose Am J Kidney Dis 38 5 2001 988 991
69. K.A. Moniem, and S. Bhandari Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations Transfus Altern Transfus Med 9 1 2007 37 42
70. J. Critchley, and Y. Dundar Adverse events associated with intravenous iron infusion (low-molecular-weight iron dextran and iron sucrose): a systematic review Transfus Altern Transfus Med 9 2007 8 36
71. T. Sav, B. Tokgoz, and M.H. Sipahioglu Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail 29 4 2007 423 426
72. Macdougall IC, McGlaughlin J, Fortin GS. FIRST: head-to-head comparison study (Ferumoxytol compared to Iron Sucrose Trial) of the safety and efficacy of ferumoxytol with iron sucrose for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD) 2011. 6B2011.
73. M.M. Okam, E. Mandell, and N. Hevelone Comparative rates of adverse events with different formulations of intravenous iron Am J Hematol 87 11 2012 E123 E124
74. Y. Solak, H. Atalay, and I. Guney Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients Ren Fail 33 3 2011 307 311
75. B. Bastani, and S. Galley Intraperitoneal iron-dextran as a potential route of iron therapy in CAPD patients Perit Dial Int 16 6 1996 646 648
76. S. Prakash, A. Walele, and N. Dimkovic Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients Perit Dial Int 21 3 2001 290 295
77. M. Auerbach, M. Chaudhry, and H. Goldman Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial J Lab Clin Med 131 3 1998 257 260
78. M. Auerbach, H. Ballard, and J. Glaspy Clinical update: intravenous iron for anaemia Lancet 369 9572 2007 1502 1504
79. S. Fishbane, V.D. Ungureanu, and J.K. Maesaka The safety of intravenous iron dextran in hemodialysis patients Am J Kidney Dis 28 4 1996 529 534